 | • レポートコード：MRC2012A7686 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肺用ドラッグデリバリーデバイスの世界市場を広く調査・分析し、今後の市場展望をまとめております。肺用ドラッグデリバリーデバイスの種類別市場規模（ドライパウダー吸入器、定量吸入器、ネブライザー）、用途別市場規模（喘息、COPD、嚢胞性線維症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Boehringer Ingelheim GmbH、Bristol-Myers Squibb、AstraZeneca、Novartis AG、MannKind、GlaxoSmithKline、Omron Corp、Merck、Teva Pharmaceutical Industries、Mylan N.V、Gerresheimer AG、SHL Group、F. Hoffmann-La Roche、Hovione、Bespak、Koninklijke Philips N.V、3M Healthcare、Nypro Healthcare、AptarGroup、Sunovion Pharmaceuticals、Chiesi Farmaceutici S.P.A、 ・地域別グローバル市場分析 2015年-2020年 ・肺用ドラッグデリバリーデバイスの北米市場（アメリカ、カナダ、メキシコ） ・肺用ドラッグデリバリーデバイスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肺用ドラッグデリバリーデバイスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肺用ドラッグデリバリーデバイスの南米市場（ブラジル、アルゼンチン） ・肺用ドラッグデリバリーデバイスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ドライパウダー吸入器、定量吸入器、ネブライザー ・用途別分析：喘息、COPD、嚢胞性線維症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pulmonary Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 3368.7 million by 2025, from USD 2877.4 million in 2019.
The Pulmonary Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pulmonary Drug Delivery Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pulmonary Drug Delivery Devices market has been segmented into
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
By Application, Pulmonary Drug Delivery Devices has been segmented into:
Asthma
COPD
Cystic Fibrosis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pulmonary Drug Delivery Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Pulmonary Drug Delivery Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pulmonary Drug Delivery Devices market.
The report offers in-depth assessment of the growth and other aspects of the Pulmonary Drug Delivery Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pulmonary Drug Delivery Devices Market Share Analysis
Pulmonary Drug Delivery Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pulmonary Drug Delivery Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pulmonary Drug Delivery Devices sales, revenue and market share for each player covered in this report.
The major players covered in Pulmonary Drug Delivery Devices are:
Boehringer Ingelheim GmbH
Bristol-Myers Squibb
AstraZeneca
Novartis AG
MannKind
GlaxoSmithKline
Omron Corp
Merck
Teva Pharmaceutical Industries
Mylan N.V
Gerresheimer AG
SHL Group
F. Hoffmann-La Roche
Hovione
Bespak
Koninklijke Philips N.V
3M Healthcare
Nypro Healthcare
AptarGroup
Sunovion Pharmaceuticals
Chiesi Farmaceutici S.P.A
Among other players domestic and global, Pulmonary Drug Delivery Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Devices, with price, sales, revenue and global market share of Pulmonary Drug Delivery Devices in 2018 and 2019.
Chapter 3, the Pulmonary Drug Delivery Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pulmonary Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pulmonary Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pulmonary Drug Delivery Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pulmonary Drug Delivery Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Dry Powder Inhaler
1.2.3 Metered Dose Inhaler
1.2.4 Nebulizer
1.3 Market Analysis by Application
1.3.1 Overview: Global Pulmonary Drug Delivery Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Asthma
1.3.3 COPD
1.3.4 Cystic Fibrosis
1.3.5 Other
1.4 Overview of Global Pulmonary Drug Delivery Devices Market
1.4.1 Global Pulmonary Drug Delivery Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim GmbH
2.1.1 Boehringer Ingelheim GmbH Details
2.1.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim GmbH SWOT Analysis
2.1.4 Boehringer Ingelheim GmbH Product and Services
2.1.5 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca SWOT Analysis
2.3.4 AstraZeneca Product and Services
2.3.5 AstraZeneca Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 MannKind
2.5.1 MannKind Details
2.5.2 MannKind Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MannKind SWOT Analysis
2.5.4 MannKind Product and Services
2.5.5 MannKind Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Omron Corp
2.7.1 Omron Corp Details
2.7.2 Omron Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Omron Corp SWOT Analysis
2.7.4 Omron Corp Product and Services
2.7.5 Omron Corp Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva Pharmaceutical Industries
2.9.1 Teva Pharmaceutical Industries Details
2.9.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Teva Pharmaceutical Industries SWOT Analysis
2.9.4 Teva Pharmaceutical Industries Product and Services
2.9.5 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan N.V
2.10.1 Mylan N.V Details
2.10.2 Mylan N.V Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mylan N.V SWOT Analysis
2.10.4 Mylan N.V Product and Services
2.10.5 Mylan N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Gerresheimer AG
2.11.1 Gerresheimer AG Details
2.11.2 Gerresheimer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Gerresheimer AG SWOT Analysis
2.11.4 Gerresheimer AG Product and Services
2.11.5 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 SHL Group
2.12.1 SHL Group Details
2.12.2 SHL Group Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 SHL Group SWOT Analysis
2.12.4 SHL Group Product and Services
2.12.5 SHL Group Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 F. Hoffmann-La Roche
2.13.1 F. Hoffmann-La Roche Details
2.13.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 F. Hoffmann-La Roche SWOT Analysis
2.13.4 F. Hoffmann-La Roche Product and Services
2.13.5 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hovione
2.14.1 Hovione Details
2.14.2 Hovione Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hovione SWOT Analysis
2.14.4 Hovione Product and Services
2.14.5 Hovione Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bespak
2.15.1 Bespak Details
2.15.2 Bespak Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bespak SWOT Analysis
2.15.4 Bespak Product and Services
2.15.5 Bespak Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Koninklijke Philips N.V
2.16.1 Koninklijke Philips N.V Details
2.16.2 Koninklijke Philips N.V Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Koninklijke Philips N.V SWOT Analysis
2.16.4 Koninklijke Philips N.V Product and Services
2.16.5 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 3M Healthcare
2.17.1 3M Healthcare Details
2.17.2 3M Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 3M Healthcare SWOT Analysis
2.17.4 3M Healthcare Product and Services
2.17.5 3M Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Nypro Healthcare
2.18.1 Nypro Healthcare Details
2.18.2 Nypro Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Nypro Healthcare SWOT Analysis
2.18.4 Nypro Healthcare Product and Services
2.18.5 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 AptarGroup
2.19.1 AptarGroup Details
2.19.2 AptarGroup Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 AptarGroup SWOT Analysis
2.19.4 AptarGroup Product and Services
2.19.5 AptarGroup Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.20 Sunovion Pharmaceuticals
2.20.1 Sunovion Pharmaceuticals Details
2.20.2 Sunovion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Sunovion Pharmaceuticals SWOT Analysis
2.20.4 Sunovion Pharmaceuticals Product and Services
2.20.5 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.21 Chiesi Farmaceutici S.P.A
2.21.1 Chiesi Farmaceutici S.P.A Details
2.21.2 Chiesi Farmaceutici S.P.A Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Chiesi Farmaceutici S.P.A SWOT Analysis
2.21.4 Chiesi Farmaceutici S.P.A Product and Services
2.21.5 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pulmonary Drug Delivery Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pulmonary Drug Delivery Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Pulmonary Drug Delivery Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Pulmonary Drug Delivery Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.3 Europe Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.5 South America Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Country
5.1.1 North America Pulmonary Drug Delivery Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Pulmonary Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
5.3 Canada Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Pulmonary Drug Delivery Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pulmonary Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.3 UK Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.4 France Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.5 Russia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
6.6 Italy Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pulmonary Drug Delivery Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pulmonary Drug Delivery Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.3 Japan Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.4 Korea Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.5 India Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
7.7 Australia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Country
8.1.1 South America Pulmonary Drug Delivery Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Pulmonary Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pulmonary Drug Delivery Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pulmonary Drug Delivery Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pulmonary Drug Delivery Devices Sales and Market Share by Type (2015-2020)
10.2 Global Pulmonary Drug Delivery Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Pulmonary Drug Delivery Devices Price by Type (2015-2020)
11 Global Pulmonary Drug Delivery Devices Market Segment by Application
11.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2015-2020)
11.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Application (2015-2020)
11.3 Global Pulmonary Drug Delivery Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pulmonary Drug Delivery Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Pulmonary Drug Delivery Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Pulmonary Drug Delivery Devices Market Forecast (2021-2025)
12.2.2 Europe Pulmonary Drug Delivery Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pulmonary Drug Delivery Devices Market Forecast (2021-2025)
12.2.4 South America Pulmonary Drug Delivery Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pulmonary Drug Delivery Devices Market Forecast (2021-2025)
12.3 Pulmonary Drug Delivery Devices Market Forecast by Type (2021-2025)
12.3.1 Global Pulmonary Drug Delivery Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Pulmonary Drug Delivery Devices Market Share Forecast by Type (2021-2025)
12.4 Pulmonary Drug Delivery Devices Market Forecast by Application (2021-2025)
12.4.1 Global Pulmonary Drug Delivery Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Pulmonary Drug Delivery Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pulmonary Drug Delivery Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pulmonary Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pulmonary Drug Delivery Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Major Business
Table 9. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 10. Boehringer Ingelheim GmbH SWOT Analysis
Table 11. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
Table 12. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Major Business
Table 15. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
Table 18. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Pulmonary Drug Delivery Devices Major Business
Table 21. AstraZeneca Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 22. AstraZeneca SWOT Analysis
Table 23. AstraZeneca Pulmonary Drug Delivery Devices Product and Services
Table 24. AstraZeneca Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG Pulmonary Drug Delivery Devices Major Business
Table 27. Novartis AG Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG Pulmonary Drug Delivery Devices Product and Services
Table 30. Novartis AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. MannKind Basic Information, Manufacturing Base and Competitors
Table 32. MannKind Pulmonary Drug Delivery Devices Major Business
Table 33. MannKind Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 34. MannKind SWOT Analysis
Table 35. MannKind Pulmonary Drug Delivery Devices Product and Services
Table 36. MannKind Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 38. GlaxoSmithKline Pulmonary Drug Delivery Devices Major Business
Table 39. GlaxoSmithKline Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 40. GlaxoSmithKline SWOT Analysis
Table 41. GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
Table 42. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Omron Corp Basic Information, Manufacturing Base and Competitors
Table 44. Omron Corp Pulmonary Drug Delivery Devices Major Business
Table 45. Omron Corp Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 46. Omron Corp SWOT Analysis
Table 47. Omron Corp Pulmonary Drug Delivery Devices Product and Services
Table 48. Omron Corp Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Pulmonary Drug Delivery Devices Major Business
Table 51. Merck Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 52. Merck SWOT Analysis
Table 53. Merck Pulmonary Drug Delivery Devices Product and Services
Table 54. Merck Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 56. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Major Business
Table 57. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 58. Teva Pharmaceutical Industries SWOT Analysis
Table 59. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
Table 60. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 62. Mylan N.V Pulmonary Drug Delivery Devices Major Business
Table 63. Mylan N.V Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 64. Mylan N.V SWOT Analysis
Table 65. Mylan N.V Pulmonary Drug Delivery Devices Product and Services
Table 66. Mylan N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 68. Gerresheimer AG Pulmonary Drug Delivery Devices Major Business
Table 69. Gerresheimer AG Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 70. Gerresheimer AG SWOT Analysis
Table 71. Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
Table 72. Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. SHL Group Basic Information, Manufacturing Base and Competitors
Table 74. SHL Group Pulmonary Drug Delivery Devices Major Business
Table 75. SHL Group Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 76. SHL Group SWOT Analysis
Table 77. SHL Group Pulmonary Drug Delivery Devices Product and Services
Table 78. SHL Group Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 80. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Major Business
Table 81. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 82. F. Hoffmann-La Roche SWOT Analysis
Table 83. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
Table 84. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Hovione Basic Information, Manufacturing Base and Competitors
Table 86. Hovione Pulmonary Drug Delivery Devices Major Business
Table 87. Hovione Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 88. Hovione SWOT Analysis
Table 89. Hovione Pulmonary Drug Delivery Devices Product and Services
Table 90. Hovione Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Bespak Basic Information, Manufacturing Base and Competitors
Table 92. Bespak Pulmonary Drug Delivery Devices Major Business
Table 93. Bespak Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 94. Bespak SWOT Analysis
Table 95. Bespak Pulmonary Drug Delivery Devices Product and Services
Table 96. Bespak Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Koninklijke Philips N.V Basic Information, Manufacturing Base and Competitors
Table 98. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Major Business
Table 99. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 100. Koninklijke Philips N.V SWOT Analysis
Table 101. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
Table 102. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. 3M Healthcare Basic Information, Manufacturing Base and Competitors
Table 104. 3M Healthcare Pulmonary Drug Delivery Devices Major Business
Table 105. 3M Healthcare Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 106. 3M Healthcare SWOT Analysis
Table 107. 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 108. 3M Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Nypro Healthcare Pulmonary Drug Delivery Devices Type and Application
Table 110. Nypro Healthcare Pulmonary Drug Delivery Devices Major Business
Table 111. Nypro Healthcare Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 112. Nypro Healthcare SWOT Analysis
Table 113. Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 114. Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. AptarGroup Basic Information, Manufacturing Base and Competitors
Table 116. AptarGroup Pulmonary Drug Delivery Devices Major Business
Table 117. AptarGroup Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 118. AptarGroup SWOT Analysis
Table 119. AptarGroup Pulmonary Drug Delivery Devices Product and Services
Table 120. AptarGroup Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Sunovion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Major Business
Table 123. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 124. Sunovion Pharmaceuticals SWOT Analysis
Table 125. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
Table 126. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 127. Chiesi Farmaceutici S.P.A Basic Information, Manufacturing Base and Competitors
Table 128. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Major Business
Table 129. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Total Revenue (USD Million) (2017-2018)
Table 130. Chiesi Farmaceutici S.P.A SWOT Analysis
Table 131. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
Table 132. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 133. Global Pulmonary Drug Delivery Devices Sales by Manufacturer (2018-2019) (K Units)
Table 134. Global Pulmonary Drug Delivery Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 135. Global Pulmonary Drug Delivery Devices Sales by Regions (2015-2020) (K Units)
Table 136. Global Pulmonary Drug Delivery Devices Sales Market Share by Regions (2015-2020)
Table 137. Global Pulmonary Drug Delivery Devices Revenue by Regions (2015-2020) (USD Million)
Table 138. North America Pulmonary Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 139. North America Pulmonary Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 140. North America Pulmonary Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 141. North America Pulmonary Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Table 142. Europe Pulmonary Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 143. Europe Pulmonary Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 144. Europe Pulmonary Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 145. Asia-Pacific Pulmonary Drug Delivery Devices Sales by Regions (2015-2020) (K Units)
Table 146. Asia-Pacific Pulmonary Drug Delivery Devices Sales Market Share by Regions (2015-2020)
Table 147. Asia-Pacific Pulmonary Drug Delivery Devices Revenue by Regions (2015-2020) (USD Million)
Table 148. South America Pulmonary Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 149. South America Pulmonary Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 150. South America Pulmonary Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 151. South America Pulmonary Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Table 152. Middle East & Africa Pulmonary Drug Delivery Devices Sales by Countries (2015-2020) (K Units)
Table 153. Middle East & Africa Pulmonary Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Table 154. Middle East & Africa Pulmonary Drug Delivery Devices Revenue by Countries (2015-2020) (USD Million)
Table 155. Middle East & Africa Pulmonary Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Table 156. Global Pulmonary Drug Delivery Devices Sales by Type (2015-2020) (K Units)
Table 157. Global Pulmonary Drug Delivery Devices Sales Share by Type (2015-2020)
Table 158. Global Pulmonary Drug Delivery Devices Revenue by Type (2015-2020) (USD Million)
Table 159. Global Pulmonary Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 160. Global Pulmonary Drug Delivery Devices Sales by Application (2015-2020) (K Units)
Table 161. Global Pulmonary Drug Delivery Devices Sales Share by Application (2015-2020)
Table 162. Global Pulmonary Drug Delivery Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 163. Global Pulmonary Drug Delivery Devices Market Share Forecast by Regions (2021-2025)
Table 164. Global Pulmonary Drug Delivery Devices Sales Forecast by Type (2021-2025) (K Units)
Table 165. Global Pulmonary Drug Delivery Devices Market Share Forecast by Type (2021-2025)
Table 166. Global Pulmonary Drug Delivery Devices Sales Forecast by Application (2021-2025)
Table 167. Global Pulmonary Drug Delivery Devices Market Share Forecast by Application (2021-2025)
Table 168. Direct Channel Pros & Cons
Table 169. Indirect Channel Pros & Cons
Table 170. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pulmonary Drug Delivery Devices Picture
Figure 2. Global Sales Market Share of Pulmonary Drug Delivery Devices by Type in 2019
Figure 3. Dry Powder Inhaler Picture
Figure 4. Metered Dose Inhaler Picture
Figure 5. Nebulizer Picture
Figure 6. Pulmonary Drug Delivery Devices Sales Market Share by Application in 2018
Figure 7. Asthma Picture
Figure 8. COPD Picture
Figure 9. Cystic Fibrosis Picture
Figure 10. Other Picture
Figure 11. Global Pulmonary Drug Delivery Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Pulmonary Drug Delivery Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Pulmonary Drug Delivery Devices Sales Market Share by Manufacturer in 2019
Figure 32. Global Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Pulmonary Drug Delivery Devices Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Pulmonary Drug Delivery Devices Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Pulmonary Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Pulmonary Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
Figure 39. Global Pulmonary Drug Delivery Devices Revenue Market Share by Regions in 2018
Figure 40. North America Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 41. Europe Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 43. South America Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020)
Figure 45. North America Pulmonary Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Pulmonary Drug Delivery Devices Sales Market Share by Countries (2015-2020)
Figure 47. North America Pulmonary Drug Delivery Devices Sales Market Share by Countries in 2018
Figure 48. North America Pulmonary Drug Delivery Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Pulmonary Drug Delivery Devices Revenue Market Share by Countries in 2018
Figure 50. United States Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Pulmonary Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Countries in 2019
Figure 56. Germany Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Pulmonary Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Pulmonary Drug Delivery Devices Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Pulmonary Drug Delivery Devices Revenue Market Share by Regions 2019
Figure 64. China Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Pulmonary Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Pulmonary Drug Delivery Devices Sales Market Share by Countries in 2019
Figure 71. South America Pulmonary Drug Delivery Devices Revenue Market Share by Countries in 2019
Figure 72. Brazil Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Pulmonary Drug Delivery Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Pulmonary Drug Delivery Devices Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Pulmonary Drug Delivery Devices Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Pulmonary Drug Delivery Devices Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Pulmonary Drug Delivery Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Pulmonary Drug Delivery Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Pulmonary Drug Delivery Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Pulmonary Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Pulmonary Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Pulmonary Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Pulmonary Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Pulmonary Drug Delivery Devices Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
肺ドラッグデリバリーシステム（PDDS）の世界市場（～2026年） Market Analysis and Insights: Global Pulmonary Drug Delivery System (PDDS) Market The global Pulmonary Drug Delivery System (PDDS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pulmonary Drug Delivery System (PDDS) S…- 肺/呼吸器ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 32810 million by 2026, from US$ 31560 million in 2020, at a CAGR of 3.7%% during 2021-2026. Global Pulmonary/ Respiratory Drug Delive…
- 埋め込み型ドラッグデリバリーデバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Implantable Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 高度ドラッグデリバリーシステムの世界市場（～2026年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…